Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Onconetix (ONCO) Income from Continuing Operations (2023 - 2025)

Onconetix (ONCO) has disclosed Income from Continuing Operations for 2 consecutive years, with 29549967.0 as the latest value for Q4 2024.

  • On a quarterly basis, Income from Continuing Operations rose 234.03% to 29549967.0 in Q4 2024 year-over-year; TTM through Dec 2024 was 297286.0, a 100.8% increase, with the full-year FY2024 number at 297286.0, up 100.8% from a year prior.
  • Income from Continuing Operations was 29549967.0 for Q4 2024 at Onconetix, up from 3827405.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 29549967.0 in Q4 2024 to a low of 22047777.0 in Q4 2023.